Product NDC: | 25021-672 |
Proprietary Name: | Atracurium Besylate |
Non Proprietary Name: | atracurium besylate |
Active Ingredient(s): | 10 mg/mL & nbsp; atracurium besylate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-672 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091489 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120501 |
Package NDC: | 25021-672-10 |
Package Description: | 10 VIAL in 1 CARTON (25021-672-10) > 10 mL in 1 VIAL |
NDC Code | 25021-672-10 |
Proprietary Name | Atracurium Besylate |
Package Description | 10 VIAL in 1 CARTON (25021-672-10) > 10 mL in 1 VIAL |
Product NDC | 25021-672 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | atracurium besylate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120501 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | ATRACURIUM BESYLATE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |